| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| RAR-related orphan receptor gamma | 14 | 0 | 0 | 14 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| GLS protein | 11 | 0 | 0 | 11 |
| Microtubule-associated protein tau | 10 | 0 | 0 | 10 |
| Smad3 | 4 | 0 | 0 | 4 |
| aldehyde dehydrogenase 1 family, member A1 | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 3 | 7 | 0 | 0 | 7 |
| progesterone receptor | 11 | 0 | 0 | 11 |
| EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
| retinoic acid nuclear receptor alpha variant 1 | 18 | 0 | 0 | 18 |
| retinoid X nuclear receptor alpha | 13 | 0 | 0 | 13 |
| estrogen-related nuclear receptor alpha | 19 | 0 | 0 | 19 |
| estrogen nuclear receptor alpha | 28 | 0 | 0 | 28 |
| peroxisome proliferator activated receptor gamma | 9 | 0 | 0 | 9 |
| aryl hydrocarbon receptor | 8 | 0 | 0 | 8 |
| chromobox protein homolog 1 | 13 | 0 | 0 | 13 |
| thyroid hormone receptor beta isoform 2 | 14 | 0 | 0 | 14 |
| peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
| cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit pi | 7 | 2 | 1 | 11 |
| ATP-binding cassette sub-family C member 3 | 0 | 14 | 0 | 14 |
| Multidrug resistance-associated protein 4 | 0 | 14 | 0 | 15 |
| Solute carrier family 22 member 6 | 0 | 5 | 0 | 5 |
| Carbonic anhydrase 12 | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 4 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| Voltage-dependent calcium channel gamma-2 subunit | 11 | 0 | 0 | 11 |
| Bile salt export pump | 0 | 21 | 0 | 21 |
| Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 9 | 0 | 9 |
| Carbonic anhydrase 2 | 0 | 9 | 1 | 10 |
| Myoglobin | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
| Cytochrome P450 1A2 | 0 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 8 | 0 | 9 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Cytochrome P450 3A4 | 0 | 6 | 1 | 8 |
| Cytochrome P450 2D6 | 0 | 3 | 0 | 3 |
| Cytochrome P450 2C9 | 0 | 8 | 0 | 8 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 2 | 1 | 11 |
| Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 7 | 2 | 1 | 11 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 2 | 1 | 11 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
| Glutamate receptor 2 | 11 | 0 | 0 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 2 | 1 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 2 | 1 | 11 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 7 | 0 | 8 |
| Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 2 | 1 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 2 | 1 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 2 | 1 | 11 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 2 | 1 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 2 | 1 | 11 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 10 | 2 | 14 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
| Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 4 | 1 | 13 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 2 | 1 | 11 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 2 | 1 | 11 |
| Carbonic anhydrase 9 | 0 | 4 | 0 | 4 |
| GABA theta subunit | 7 | 2 | 1 | 11 |
| Canalicular multispecific organic anion transporter 1 | 0 | 14 | 0 | 14 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 7 | 2 | 1 | 11 |
| Carbonic anhydrase 14 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
| toxin B | 0 | 0 | 0 | 1 |
| Chain A, farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
| Geranylgeranyl pyrophosphate synthase | 0 | 5 | 0 | 6 |
| Farnesyl pyrophosphate synthase | 0 | 6 | 0 | 6 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Farnesyl pyrophosphate synthase | 0 | 5 | 0 | 5 |
| Farnesyl pyrophosphate synthase | 0 | 3 | 0 | 3 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 11 | 0 | 0 | 11 |
| Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
| Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
| Chain A, Cruzipain | 4 | 0 | 0 | 4 |
| Beta-lactamase | 0 | 2 | 0 | 4 |
| acid sphingomyelinase | 3 | 0 | 0 | 3 |
| GLI family zinc finger 3 | 17 | 0 | 0 | 17 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 4 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 3 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 22 | 0 | 0 | 22 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 7 | 0 | 0 | 7 |
| DNA polymerase beta | 4 | 0 | 0 | 4 |
| DNA polymerase eta isoform 1 | 4 | 0 | 0 | 4 |
| DNA polymerase iota isoform a (long) | 11 | 0 | 0 | 11 |
| geminin | 18 | 0 | 0 | 18 |
| DNA polymerase kappa isoform 1 | 10 | 0 | 0 | 10 |
| 60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Beta-lactamase OXA-7 | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 4 | 0 | 4 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 9 | 0 | 0 | 9 |
| 10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
| Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 3 |
| Efflux transporter | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 4 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Class D beta-lactamase | 0 | 1 | 0 | 3 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 4 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| 10 kDa chaperonin | 0 | 3 | 0 | 3 |
| Metallo-b-lactamase | 0 | 0 | 0 | 4 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 2 | 0 | 5 |
| Histamine H3 receptor | 0 | 0 | 0 | 3 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 4 |
| Beta-lactamase VIM-1 | 0 | 0 | 0 | 3 |
| ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 7 | 0 | 0 | 7 |
| AR protein | 23 | 0 | 0 | 23 |
| thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 17 | 0 | 0 | 17 |
| glucocorticoid receptor [Homo sapiens] | 17 | 0 | 0 | 17 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 17 | 0 | 0 | 17 |
| IDH1 | 11 | 0 | 0 | 11 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 8 | 0 | 0 | 8 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 16 | 0 | 0 | 16 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| lamin isoform A-delta10 | 13 | 0 | 0 | 13 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 2 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 3 | 0 | 3 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 4 | 1 | 5 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 7 | 0 | 0 | 7 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
| GTP-binding protein (rab7) | 0 | 0 | 2 | 2 |
| ras protein, partial | 0 | 0 | 2 | 2 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| thioredoxin reductase | 10 | 0 | 0 | 10 |
| hypothetical protein, conserved | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 | 10 | 0 | 0 | 10 |
| glucocerebrosidase | 5 | 0 | 0 | 5 |
| peroxisome proliferator-activated receptor delta | 9 | 0 | 0 | 9 |
| Rac1 protein | 0 | 0 | 2 | 2 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 2 | 2 |
| Bloom syndrome protein isoform 1 | 6 | 0 | 0 | 6 |
| muscarinic acetylcholine receptor M1 | 5 | 0 | 0 | 5 |
| Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 5 |
| Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
| Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
| Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
| Integrin beta-3 | 3 | 1 | 0 | 4 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 2 | 0 | 2 |
| Integrin alpha-IIb | 3 | 1 | 0 | 4 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 5 | 0 | 5 |
| Adenosine receptor A2a | 0 | 3 | 0 | 3 |
| Substance-P receptor | 0 | 4 | 0 | 4 |
| Urotensin-2 receptor | 0 | 2 | 0 | 2 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 2 | 0 | 2 |
| Ras-related protein Rab-2A | 0 | 0 | 2 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 7 | 0 | 7 |
| Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
| Nicotinate phosphoribosyltransferase | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 6 | 1 | 7 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
| Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 2 | 1 | 3 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 7 | 0 | 9 |
| Kappa-type opioid receptor | 0 | 8 | 2 | 11 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 4 | 0 | 0 | 4 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
| SMAD family member 2 | 7 | 0 | 0 | 7 |
| USP1 protein, partial | 8 | 0 | 0 | 8 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| SMAD family member 3 | 7 | 0 | 0 | 7 |
| TDP1 protein | 16 | 0 | 0 | 16 |
| caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 8 | 0 | 0 | 8 |
| pregnane X nuclear receptor | 12 | 0 | 0 | 12 |
| G | 9 | 0 | 0 | 9 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| 67.9K protein | 4 | 0 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| caspase-3 | 4 | 0 | 0 | 4 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 11 | 0 | 0 | 11 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| activating transcription factor 6 | 5 | 0 | 0 | 5 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 7 | 0 | 0 | 7 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 9 | 0 | 0 | 9 |
| Histone H2A.x | 8 | 0 | 0 | 8 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
| caspase-3 | 2 | 0 | 0 | 2 |
| heat shock protein beta-1 | 6 | 0 | 0 | 6 |
| Prostaglandin E synthase | 0 | 2 | 0 | 2 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Cytochrome c oxidase subunit 1 | 0 | 1 | 0 | 1 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Cytochrome c oxidase subunit 2 | 0 | 2 | 0 | 2 |
| Interferon beta | 11 | 0 | 0 | 11 |
| HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
| Cellular tumor antigen p53 | 13 | 0 | 0 | 13 |
| Procathepsin L | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 7 | 0 | 7 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 2 | 0 | 3 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 2 | 0 | 3 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 5 | 0 | 5 |
| Calpain-2 catalytic subunit | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 4 | 0 | 4 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 5 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 3 | 1 | 4 |
| Delta-type opioid receptor | 0 | 5 | 0 | 6 |
| Delta-type opioid receptor | 0 | 8 | 1 | 10 |
| Mu-type opioid receptor | 0 | 8 | 2 | 13 |
| Bifunctional epoxide hydrolase 2 | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 5 | 0 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 3 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 7 | 0 | 7 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 4 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 3 | 0 | 3 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Cyclooxygenase-2 | 0 | 2 | 0 | 2 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 8 | 0 | 0 | 8 |
| Ataxin-2 | 8 | 0 | 0 | 8 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 5 | 0 | 0 | 5 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 6 | 0 | 0 | 6 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| WRN | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 8 | 0 | 0 | 8 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| vitamin D3 receptor isoform VDRA | 10 | 0 | 0 | 10 |
| DNA (cytosine-5)-methyltransferase 1 isoform b | 0 | 1 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 5 | 0 | 0 | 5 |
| flap endonuclease 1 | 4 | 0 | 0 | 4 |
| serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
| snurportin-1 | 5 | 0 | 0 | 5 |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 3 | 0 | 5 |
| Beta-lactamase SHV-1 | 0 | 1 | 0 | 3 |
| Beta-lactamase SHV-1 | 0 | 2 | 0 | 4 |
| Beta-lactamase OXA-1 | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase TEM | 0 | 2 | 0 | 3 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 4 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 4 | 0 | 5 |
| Solute carrier family 22 member 11 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 7 | 0 | 7 |
| Cytochrome P450 2D1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D26 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D3 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 5 |
| Kappa-type opioid receptor | 0 | 3 | 2 | 6 |
| Mu-type opioid receptor | 0 | 11 | 5 | 17 |
| Delta-type opioid receptor | 0 | 7 | 2 | 10 |
| Mu-type opioid receptor | 0 | 4 | 2 | 8 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 9 | 0 | 9 |
| Cytochrome P450 2D4 | 0 | 1 | 0 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 3 | 3 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| Cereblon isoform 4 | 0 | 2 | 0 | 2 |
| Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Protein cereblon | 0 | 2 | 0 | 2 |
| Genome polyprotein | 0 | 2 | 1 | 3 |
| Luciferase | 5 | 0 | 0 | 5 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 4 | 0 | 0 | 4 |
| polyprotein | 4 | 0 | 0 | 4 |
| bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| eyes absent homolog 2 isoform a | 2 | 0 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| large T antigen | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 0 | 4 |
| Type IV secretion-like conjugative transfer relaxase protein TraI | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 8 | 0 | 9 |
| D(2) dopamine receptor | 0 | 4 | 1 | 7 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 4 | 1 | 7 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 6 | 1 | 8 |
| Histamine H1 receptor | 0 | 3 | 0 | 3 |
| D(3) dopamine receptor | 0 | 4 | 1 | 7 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Asialoglycoprotein receptor 1 | 0 | 1 | 1 | 2 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
| nonstructural protein 1 | 6 | 0 | 0 | 6 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
| transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| Albumin | 0 | 0 | 2 | 2 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Vitamin D-binding protein | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 2 | 2 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M3 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 4 |
| Muscarinic acetylcholine receptor M5 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 4 | 1 | 5 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 3 | 0 | 3 |
| D | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
| Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Histamine H2 receptor | 5 | 0 | 0 | 6 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
| N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 6 | 0 | 0 | 6 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
| Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
| Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Zinc finger protein 664 | 0 | 1 | 0 | 1 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Protease | 0 | 2 | 0 | 2 |
| Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Albumin | 0 | 3 | 4 | 7 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
| Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 3 | 0 | 4 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 4 |
| Caspase-1 | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
| Aldo-keto reductase family 1 member C3 | 0 | 3 | 0 | 3 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
| Caspase-4 | 0 | 1 | 0 | 1 |
| Caspase-5 | 0 | 1 | 0 | 1 |
| Caspase-9 | 0 | 1 | 0 | 1 |
| Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
| Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 4 | 0 | 0 | 4 |
| Parkin | 3 | 0 | 0 | 3 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
| Interleukin-8 | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 2 | 1 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 2 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
| C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 2 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 3 |
| Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
| Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
| Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 6 | 0 | 0 | 6 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 1 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Protein-arginine deiminase type-4 | 0 | 5 | 0 | 5 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
| Glucocorticoid receptor | 0 | 4 | 1 | 10 |
| Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
| Androgen receptor | 0 | 5 | 0 | 5 |
| Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Translocator protein | 0 | 1 | 1 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 1 | 0 | 1 |
| Matrilysin | 0 | 1 | 0 | 1 |
| Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | 0 | 1 | 0 | 1 |
| Valosin-containing protein | 0 | 1 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 3 | 0 | 0 | 3 |
| Estrogen receptor 1 | 0 | 1 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| fMet-Leu-Phe receptor | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
| BlaVIM-1 | 0 | 0 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 3 | 0 | 3 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 3 | 0 | 3 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
| Chain A, dATP pyrophosphohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
| Chain B, Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase, beta polypeptide | 0 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 1 | 0 | 1 |
| Gastric inhibitory polypeptide receptor | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 1 | 0 | 1 |
| Butyrophilin subfamily 3 member A1 | 0 | 0 | 2 | 3 |
| 4-hydroxy-3-methylbut-2-enyl diphosphate reductase | 0 | 1 | 0 | 1 |
| Farnesyl diphosphate synthase | 0 | 1 | 0 | 1 |
| H | 0 | 2 | 0 | 2 |
| Phosphotransferase | 0 | 1 | 0 | 1 |
| Farnesyl diphosphate synthase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Sialidase | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Neuromedin-U receptor 2 | 0 | 0 | 1 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase L1 type 3 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Protein Rev | 0 | 0 | 1 | 1 |
| D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| Vitamin D3 receptor | 0 | 0 | 0 | 1 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Neutrophil collagenase | 0 | 1 | 0 | 1 |
| Farnesyl diphosphate synthase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
| Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |